Davidson Kempner Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-264,761
Closed -$20.7M 492
2020
Q4
$20.7M Buy
264,761
+19,597
+8% +$1.5M 0.24% 90
2020
Q3
$19.4M Buy
+245,164
New +$19.2M 0.28% 79
2020
Q2
Sell
-163,069
Closed -$12M 202
2020
Q1
$12M Buy
163,069
+57,292
+54% +$4.5M 0.32% 68
2019
Q4
$9.18M Buy
105,777
+80,853
+324% +$6.64M 0.21% 92
2019
Q3
$2M Buy
+24,924
New +$2M 0.04% 123
2017
Q3
Sell
-78,600
Closed -$4.81M 204
2017
Q2
$4.81M Buy
+78,600
New +$4.78M 0.07% 132

Other funds holding MRK

Davidson Kempner Capital Management's MRK Position: Q1 2021 in Review

Davidson Kempner Capital Management sold out of Merck (MRK) in Q1 2021, closing a stake of 264,761 shares — an estimated $20.7M sold.

Davidson Kempner Capital Management first reported a position in MRK in Q2 2017 and held it in 6 quarters. The position peaked at $20.7M in Q4 2020. 2,686 funds tracked by Wall St. Rank hold MRK as of Q1 2021.

  • Davidson Kempner Capital Management reported no remaining Merck position as of Q1 2021 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 264,761 Merck shares in Q1 2021, an estimated $20.7M.
  • Davidson Kempner Capital Management first reported a position in Merck in Q2 2017 and held it in 6 quarters.
  • Davidson Kempner Capital Management's Merck position peaked at $20.7M in Q4 2020.
  • 2,686 funds tracked by Wall St. Rank held Merck as of Q1 2021.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2021, filed 17 May 2021.